PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2932340-0	1985	Modulation of complement receptors of a human monocyte cell line, U-937, during incubation with phorbol myristate acetate: expression of an iC3b-specific receptor (CR3).	Tetradecanoylphorbol Acetate	96-121	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	164-167	
2958480-7	1987	Stimulation of PMN for 25 min with phorbol myristate acetate (PMA) dramatically enhances binding of C3bi-coated particles, and the CR3 on such stimulated cells was observed in clusters containing more than six gold particles.	Tetradecanoylphorbol Acetate	35-60	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	131-134	
2958480-7	1987	Stimulation of PMN for 25 min with phorbol myristate acetate (PMA) dramatically enhances binding of C3bi-coated particles, and the CR3 on such stimulated cells was observed in clusters containing more than six gold particles.	Tetradecanoylphorbol Acetate	62-65	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	131-134	
2953669-6	1987	Expression of both receptors increased in a dose-dependent manner after incubation with f-met-leu-phe or phorbol myristate acetate; however, only CR3 expression was enhanced at very low concentrations of these stimuli.	Tetradecanoylphorbol Acetate	105-130	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	146-149	
3159792-8	1985	Phorbol myristate acetate (0.1 ng/ml) increased CR1 230% and CR3 265%.	Tetradecanoylphorbol Acetate	0-25	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	61-64	
16374778-6	2006	PMA, which mimics diacylglycerol (DAG) as an activator of cPKC, novel-PKC (nPKC), and non-PKC DAG-driven molecule(s), produced a dose-dependent dual effect on phagocytosis by CR3/MAC-1 and SRAI/II, i.e., augmentation at low concentrations and inhibition at high concentrations.	Tetradecanoylphorbol Acetate	0-3	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	175-178	
16374778-7	2006	Inhibition of phagocytosis by CR3/MAC-1 was enhanced by combining inhibiting concentrations of PMA with PKC inhibitors Go-6976 or Ro-318220, suggesting inhibition by PMA/DAG-driven non-PKC molecule(s).	Tetradecanoylphorbol Acetate	95-98	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	30-33	
15527172-2	2004	Exposure of resting and phorbol-12-myristate-13-acetate (PMA) stimulated human neutrophils to potassium humate resulted in a decreased expression of CR3 by activated, but not resting cells, in a dose-related way.	Tetradecanoylphorbol Acetate	24-55	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	149-152	
15527172-2	2004	Exposure of resting and phorbol-12-myristate-13-acetate (PMA) stimulated human neutrophils to potassium humate resulted in a decreased expression of CR3 by activated, but not resting cells, in a dose-related way.	Tetradecanoylphorbol Acetate	57-60	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	149-152	
15527172-3	2004	Humate also inhibited the adhesion of PMA-stimulated neutrophils to a baby hamster kidney cell line expressing ICAM1 (the CR3 ligand) (BHK331-7).	Tetradecanoylphorbol Acetate	38-41	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	122-125	
10529599-5	1999	RESULTS: Mean fluorescent intensity (MFI) of CR3 and LFA1-beta stimulated by PMA and ionomycin was significantly higher than that of the unstimulated control.	Tetradecanoylphorbol Acetate	77-80	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	45-48	
1345807-5	1992	However, treatment of leukocytes with phorbol 12-myristate 13 acetate increased CR3 and CR4 expression on both myeloid cells and a lymphocyte subpopulation.	Tetradecanoylphorbol Acetate	38-69	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	80-83	
2032553-1	1991	Treatment of neutrophils with phorbol myristate acetate (PMA) increases surface expression of CR3 (iC3b-receptor; CD11b/CD18).	Tetradecanoylphorbol Acetate	30-55	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	94-97	
2032553-1	1991	Treatment of neutrophils with phorbol myristate acetate (PMA) increases surface expression of CR3 (iC3b-receptor; CD11b/CD18).	Tetradecanoylphorbol Acetate	57-60	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	94-97